These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 27143671)

  • 21. High colonization rates of extended-spectrum β-lactamase (ESBL)-producing Escherichia coli in Swiss travellers to South Asia- a prospective observational multicentre cohort study looking at epidemiology, microbiology and risk factors.
    Kuenzli E; Jaeger VK; Frei R; Neumayr A; DeCrom S; Haller S; Blum J; Widmer AF; Furrer H; Battegay M; Endimiani A; Hatz C
    BMC Infect Dis; 2014 Oct; 14():528. PubMed ID: 25270732
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence and risk factors of infections caused by extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae.
    Nakai H; Hagihara M; Kato H; Hirai J; Nishiyama N; Koizumi Y; Sakanashi D; Suematsu H; Yamagishi Y; Mikamo H
    J Infect Chemother; 2016 May; 22(5):319-26. PubMed ID: 26968486
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High burden of extended-spectrum β-lactamase-producing Enterobacteriaceae in Gabon.
    Schaumburg F; Alabi A; Kokou C; Grobusch MP; Köck R; Kaba H; Becker K; Adegnika AA; Kremsner PG; Peters G; Mellmann A
    J Antimicrob Chemother; 2013 Sep; 68(9):2140-3. PubMed ID: 23645586
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A multinational survey of risk factors for infection with extended-spectrum beta-lactamase-producing enterobacteriaceae in nonhospitalized patients.
    Ben-Ami R; Rodríguez-Baño J; Arslan H; Pitout JD; Quentin C; Calbo ES; Azap OK; Arpin C; Pascual A; Livermore DM; Garau J; Carmeli Y
    Clin Infect Dis; 2009 Sep; 49(5):682-90. PubMed ID: 19622043
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acquisition of extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-PE) carriage after exposure to systemic antimicrobials during travel: Systematic review and meta-analysis.
    Wuerz TC; Kassim SS; Atkins KE
    Travel Med Infect Dis; 2020; 37():101823. PubMed ID: 32755674
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low rate of gut colonization by extended-spectrum β-lactamase producing Enterobacteriaceae in HIV infected persons as compared to healthy individuals in Nepal.
    Hosuru Subramanya S; Bairy I; Nayak N; Padukone S; Sathian B; Gokhale S
    PLoS One; 2019; 14(2):e0212042. PubMed ID: 30779752
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of plasmid-mediated β-lactamases in fecal colonizing patients in the hospital and community setting in Spain.
    Garrido A; Seral C; Gude MJ; Casado C; González-Domínguez M; Sáenz Y; Castillo FJ
    Microb Drug Resist; 2014 Aug; 20(4):301-4. PubMed ID: 24328895
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High Gastrointestinal Colonization Rate with Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae in Hospitalized Patients: Emergence of Carbapenemase-Producing K. pneumoniae in Ethiopia.
    Desta K; Woldeamanuel Y; Azazh A; Mohammod H; Desalegn D; Shimelis D; Gulilat D; Lamisso B; Makonnen E; Worku A; Mannerqvist K; Struwe J; Aspevall O; Aklillu E
    PLoS One; 2016; 11(8):e0161685. PubMed ID: 27574974
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Individual- and community-level risk factors for ESBL Enterobacteriaceae colonization identified by universal admission screening in London.
    Otter JA; Natale A; Batra R; Tosas Auguet O; Dyakova E; Goldenberg SD; Edgeworth JD
    Clin Microbiol Infect; 2019 Oct; 25(10):1259-1265. PubMed ID: 30849431
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence and characterization of extended-spectrum beta-lactamases producing Enterobacteriaceae in healthy children and associated risk factors.
    Hijazi SM; Fawzi MA; Ali FM; Abd El Galil KH
    Ann Clin Microbiol Antimicrob; 2016 Jan; 15():3. PubMed ID: 26823288
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence and risk factors for colonization by Clostridium difficile and extended-spectrum β-lactamase-producing Enterobacteriaceae in rehabilitation clinics in Germany.
    Arvand M; Ruscher C; Bettge-Weller G; Goltz M; Pfeifer Y
    J Hosp Infect; 2018 Jan; 98(1):14-20. PubMed ID: 28705583
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fecal Carriage of Enterobacteriaceae Producing Extended-Spectrum Beta-Lactamases in Hospitalized Patients and Healthy Community Volunteers in Burkina Faso.
    Ouédraogo AS; Sanou S; Kissou A; Poda A; Aberkane S; Bouzinbi N; Nacro B; Ouédraogo R; Van De Perre P; Carriere C; Decré D; Jean-Pierre H; Godreuil S
    Microb Drug Resist; 2017 Jan; 23(1):63-70. PubMed ID: 27092971
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Current status of extended spectrum β-lactamase-producing Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis in Okinawa prefecture, Japan.
    Nakama R; Shingaki A; Miyazato H; Higa R; Nagamoto C; Hamamoto K; Ueda S; Hachiman T; Touma Y; Miyagi K; Kawahara R; Toyosato T; Hirai I
    J Infect Chemother; 2016 May; 22(5):281-6. PubMed ID: 26898665
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk factors for colonization with extended-spectrum beta-lactamase-producing enterobacteriaceae on admission to rehabilitation centres.
    Bilavsky E; Temkin E; Lerman Y; Rabinovich A; Salomon J; Lawrence C; Rossini A; Salvia A; Samso JV; Fierro J; Paul M; Hart J; Gniadkowski M; Hochman M; Kazma M; Klein A; Adler A; Schwaber MJ; Carmeli Y;
    Clin Microbiol Infect; 2014 Nov; 20(11):O804-10. PubMed ID: 24674024
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bloodstream infection with extended-spectrum beta-lactamase-producing Enterobacteriaceae at a tertiary care hospital in New Zealand: risk factors and outcomes.
    Freeman JT; McBride SJ; Nisbet MS; Gamble GD; Williamson DA; Taylor SL; Holland DJ
    Int J Infect Dis; 2012 May; 16(5):e371-4. PubMed ID: 22401750
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessment of prevalence and changing epidemiology of extended-spectrum beta-lactamase-producing Enterobacteriaceae fecal carriers using a chromogenic medium.
    Paniagua R; Valverde A; Coque TM; Baquero F; Cantón R
    Diagn Microbiol Infect Dis; 2010 Aug; 67(4):376-9. PubMed ID: 20638607
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Extended-spectrum β-lactamase-producing Enterobacteriaceae colonisation in long-term overseas business travellers.
    Mizuno Y; Miura Y; Yamaguchi T; Matsumoto T
    Travel Med Infect Dis; 2016; 14(6):561-567. PubMed ID: 27769900
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Travel-acquired ESBL-producing Enterobacteriaceae: impact of colonization at individual and community level.
    Woerther PL; Andremont A; Kantele A
    J Travel Med; 2017 Apr; 24(suppl_1):S29-S34. PubMed ID: 28520999
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence of extended-spectrum beta-lactamase-producing Enterobacteriaceae and trends in antibiotic consumption in a county of Sweden.
    Ostholm-Balkhed A; Tärnberg M; Nilsson M; Johansson AV; Hanberger H; Monstein HJ; Nilsson LE
    Scand J Infect Dis; 2010 Dec; 42(11-12):831-8. PubMed ID: 20608768
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The prevalence and drug resistance pattern of extended spectrum β-lactamases (ESBLs) producing Enterobacteriaceae in Africa.
    Saravanan M; Ramachandran B; Barabadi H
    Microb Pathog; 2018 Jan; 114():180-192. PubMed ID: 29196174
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.